《幽门螺杆菌感染的处理:马斯特里赫特Ⅵ/佛罗伦萨共识报告》解读  

Interpretation of“Management of Helicobacter pylori Infection:the MaastrichtⅥ/Florence Consensus Report”

作　　者：刘文忠[1] LIU Wenzhong(Division of Gastroenterology and Hepatology,Renji Hospital,School of Medicine,Shanghai Jiao Tong University,Shanghai Institute of Digestive Disease,Shanghai200001)

机构地区：[1]上海交通大学医学院附属仁济医院消化内科上海市消化疾病研究所,200001

出　　处：《胃肠病学》2021年第11期676-686,共11页Chinese Journal of Gastroenterology

摘　　要：最近发表的《幽门螺杆菌感染的处理:马斯特里赫特Ⅵ/佛罗伦萨共识报告》在5个方面就幽门螺杆菌感染处理的87条陈述达成共识,包括:①适应证/关联,②诊断,③治疗,④预防/胃癌,⑤幽门螺杆菌与胃肠道菌群。本文对该共识进行详细解读。The recently published paper titled“Management of Helicobacter pylori infection:the MaastrichtⅥ/Florence consensus report”reached consensus on 87 statements concerning management of Helicobacter pylori infection in following 5 aspects:(1)indications/associations,(2)diagnosis,(3)treatment,(4)prevention/gastric cancer and(5)Helicobacter pylori and the gut microbiota.Detailed interpretations of this consensus were presented in this paper.

关 键 词：幽门螺杆菌 诊断 根除 胃癌 预防 共识 13 C-尿素呼气试验 柠檬酸 

分 类 号：R573[医药卫生—消化系统]